Furthermore, this study emphasized that the downregulation of SSTR2 resulted in enhanced apoptosis and suppressed tumour growth that was linked to the negative regulation of AMP-activated protein kinase-α (AMPK-α) and increased oxidative metabolism and suggests that SSTR2 is a poor prognostic biomarker in SCLC [360]. The gene discussed is SSTR2; the disease is small cell lung carcinoma.